Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPageGroup Regulatory News (PAGE)

Share Price Information for PageGroup (PAGE)

Share Price is delayed by 15 minutes
Get Live Data
121.90    -3.90 (-3.10%)
Bid:
122.10
Ask:
122.50
Spread: 0.40 (0.328%)
Market Cap: £379.55m
PAGE Live PriceLast checked at - London Stock Exchange

Intraday PageGroup Share Chart

EPT Disclosure - Amendment

4 Sep 2008 16:33

RNS Number : 7868C
Deutsche Bank AG
04 September 2008
 



FORM 38.5(a)

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITH RECOGNISED INTERMEDIARY STATUS

DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(a) of the Takeover Code)

Amendment - Total Buys / CFD

1. KEY INFORMATION

Name of exempt principal trader

Deutsche Bank AG London

Company dealt in

Adecco

Class of relevant security to which the dealings being disclosed relate (Note 1)

Ordinary

Date of dealing

02/09/2008

2. DEALINGS (Note 2)

(a) Purchases and sales

Total number of securities purchased

Highest price paid (Note 3)

CHF

Lowest price paid (Note 3)

CHF

22,947

53.15

52.8

Total number of securities sold

Highest price paid (Note 3)

CHF

Lowest price paid (Note 3)

CHF

19,369

53.166

52.65

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 4)

Number of securities (Note 5)

Price per unit (Note 3)

GBP

CFD

Long

6,100

52.909762

CFD

Long

2,785

52.885318

CFD

Short

12,627

52.907036

CFD

Short

1,447

52.9237

CFD

Short

1,334

52.9053

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

Date

Option money

paid/received per unit (Note 3)

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 3)

3. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Date of disclosure

04/09/2008

Contact name

Artie Movsesian

Telephone number

020 7545 7804

Name of offeree/offeror with which connected

Michael Page International Plc

Nature of connection (Note 6)

Connected Advisor to Offeree

Notes

The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMFKQKNPBKDBCK
Date   Source Headline
3rd Mar 20217:00 amRNSFinal Results
2nd Mar 20219:00 amRNSHolding(s) in Company
1st Mar 202110:09 amRNSNotice of 2020 Full Year Results
17th Feb 20213:05 pmRNSDirector Declaration
13th Jan 20217:00 amRNSFOURTH QUARTER AND FULL YEAR 2020 TRADING UPDATE
8th Jan 202110:12 amRNSNotice of Q4 and FY 2020 Trading Update
24th Dec 202010:54 amRNSBoard changes
18th Dec 202010:52 amRNSDirector Declaration
8th Dec 20201:06 pmRNSResults of External Audit Tender
7th Dec 20205:35 pmRNSDirector Declaration
14th Oct 20207:00 amRNSThird Quarter Update and COVID-19 Strategy
9th Oct 20201:32 pmRNSNotice of Third Quarter 2020 Trading Update
1st Oct 202010:14 amRNSBlock listing Interim Review
22nd Sep 20209:07 amRNSDirector Declaration
2nd Sep 20209:03 amRNSHolding(s) in Company
17th Aug 20209:45 amRNSHolding(s) in Company
5th Aug 20207:00 amRNSHalf Year Results
9th Jul 20207:00 amRNSSECOND QUARTER, FIRST HALF AND COVID-19 UPDATE
8th Jul 20209:04 amRNSNotice of Second Quarter 2020 Trading Update
4th Jun 20203:36 pmRNSResult of AGM
12th May 202011:03 amRNSNotice of 2020 Q2 Results
7th May 202011:12 amRNSHolding(s) in Company
1st May 202010:30 amRNSChange in Director’s Details
27th Apr 202012:31 pmRNSAnnual Report and Annual General Meeting
8th Apr 20207:00 amRNSFIRST QUARTER AND COVID-19 UPDATE
1st Apr 20203:00 pmRNSTotal Voting Rights
1st Apr 20201:30 pmRNSBlock listing Interim Review
20th Mar 20204:43 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
20th Mar 202011:40 amRNSHolding(s) in Company
18th Mar 20202:24 pmRNSDirector/PDMR Shareholding
16th Mar 20201:12 pmRNSDirector/PDMR Shareholding
16th Mar 20201:09 pmRNSDirector/PDMR Shareholding
10th Mar 202011:59 amRNSHolding(s) in Company
5th Mar 20207:00 amRNSFinal Results
2nd Mar 20201:14 pmRNSTotal Voting Rights
28th Feb 202011:47 amRNSNotice of 2019 Full Year Results
14th Jan 20207:00 amRNSFOURTH QUARTER AND FULL YEAR 2019 TRADING UPDATE
9th Jan 20209:46 amRNSNotice of Q4 and Full Year 2019 Trading Update
2nd Jan 20209:00 amRNSTotal Voting Rights
20th Dec 20198:44 amRNSDirector Declaration
2nd Dec 20191:36 pmRNSTotal Voting Rights
22nd Nov 20191:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20191:04 pmRNSDirector/PDMR Shareholding
8th Oct 20197:00 amRNSTHIRD QUARTER 2019 TRADING UPDATE
2nd Oct 201911:06 amRNSBlock listing Interim Review
2nd Oct 201910:03 amRNSTotal Voting Rights
21st Aug 201910:01 amRNSHolding(s) in Company
16th Aug 20199:59 amRNSHolding(s) in Company
7th Aug 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.